US Stock MarketDetailed Quotes

APTO Aptose Biosciences

Watchlist
  • 0.2516
  • -0.0215-7.87%
Trading Nov 21 14:54 ET
4.91MMarket Cap-86P/E (TTM)

About Aptose Biosciences Company

Aptose Biosciences, Inc. is a clinical-stage oncology company, which engages in the discovery, research, and development of anti-cancer therapies. Its product pipeline includes APTO-253, a small molecule that induces expression of the Kruppel-Like Factor 4 genes; and CG-806 a non-covalent small molecule therapeutic agent. The company was founded on September 5, 1986 and is headquartered in Toronto, Canada.

Company Profile

SymbolAPTO
Company NameAptose Biosciences
Listing DateOct 23, 2014
Founded1986
CEODr. William G. Rice, PhD
MarketNASDAQ
Employees36
Fiscal Year Ends12-31
AddressTD Bank Tower,66 Wellington Street West,Suite 5300
CityToronto
ProvinceOntario
CountryCanada
Zip CodeM5K 1E6
Phone1-647-479-9828
Websitehttp://www.aptose.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. William G. Rice, PhD
  • President, Chief Executive Officer and Chairman of the Board
  • 924.67K
  • Dr. Rafael Bejar, M.D.,PhD
  • Senior Vice President and Chief Medical Officer
  • 750.08K
  • Fletcher Payne
  • Principal Accounting Officer, Senior Vice President, Chief Financial Officer, Corporate Secretary and Chief Business Officer
  • 611.37K
  • Dr. Mark D. Vincent, M.D.
  • Independent Director
  • 127.68K
  • Dr. Denis R. Burger,PhD
  • Lead Independent Director
  • 172.17K
  • Warren Whitehead
  • Independent Director
  • 122.68K
  • Carol Gail Ashe
  • Independent Director
  • 123.67K
  • Dr. Erich M. Platzer, M.D.,PhD
  • Independent Director
  • 123.67K
  • Dr. Bernd R. Seizinger, M.D.,PhD
  • Independent Director
  • 132.17K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data